{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:05:30Z","timestamp":1793304330126,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.psyneuen.2017.05.005","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T18:15:19Z","timestamp":1493835319000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia"],"prefix":"10.1016","volume":"82","author":[{"given":"Laura N.","family":"Castellani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem T.","family":"Peppler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2017.05.005_bib0005","doi-asserted-by":"crossref","first-page":"e22662","DOI":"10.1371\/journal.pone.0022662","article-title":"A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers","volume":"6","author":"Albaugh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0010","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.neuropharm.2011.02.019","article-title":"Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats","volume":"62","author":"Boyda","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-511X-11-66","article-title":"Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes","volume":"11","author":"Budick-Harmelin","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0020","doi-asserted-by":"crossref","first-page":"R123","DOI":"10.1530\/JOE-14-0614","article-title":"Lack of glucagon receptor signaling and its implications beyond glucose homeostasis","volume":"224","author":"Charron","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0025","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0035","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0003-2697(83)90607-3","article-title":"An enzymatic assay for acetate in spent bacterial culture supernatants","volume":"130","author":"Clarke","year":"1983","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0040","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/JCP.0b013e3181bfe13e","article-title":"30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice","volume":"29","author":"Coccurello","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/pgs.15.55","article-title":"Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children","volume":"16","author":"Devlin","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0050","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0055","doi-asserted-by":"crossref","first-page":"e43244","DOI":"10.1371\/journal.pone.0043244","article-title":"Acute peripheral but not central administration of olanzapine induces hyperglycemia associated with hepatic and extra-hepatic insulin resistance","volume":"7","author":"Girault","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0065","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/dom.12148","article-title":"Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5'-monophosphate-activated protein kinase","volume":"15","author":"Ikegami","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0070","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0075","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/diabetes.54.5.1552","article-title":"Inhibitory effects of antipsychotics on carbachol-enhanced insulin secretion from perifused rat islets: role of muscarinic antagonism in antipsychotic-induced diabetes and hyperglycemia","volume":"54","author":"Johnson","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0080","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/schbul\/sbs196","article-title":"Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL\/6J mice","volume":"40","author":"Klingerman","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0090","doi-asserted-by":"crossref","first-page":"14972","DOI":"10.1073\/pnas.1205983109","article-title":"Metabolic manifestations of insulin deficiency do not occur without glucagon action","volume":"109","author":"Lee","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0095","doi-asserted-by":"crossref","first-page":"E563","DOI":"10.1152\/ajpendo.00287.2014","article-title":"Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice","volume":"307","author":"MacPherson","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1248\/bpb.b15-00842","article-title":"Mechanism underlying induction of hyperglycemia in rats by single administration of olanzapine","volume":"39","author":"Nagata","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0105","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.9778\/cmajo.20140009","article-title":"Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study","volume":"2","author":"Pringsheim","year":"2014","journal-title":"CMAJ Open"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","author":"Rojo","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0115","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11920-014-0473-9","article-title":"Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed","volume":"16","author":"Shams","year":"2014","journal-title":"Curr. Psychiat. Rep."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mam.2015.09.003","article-title":"Molecular pathophysiology of hepatic glucose production","volume":"46","author":"Sharabi","year":"2015","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/13813455.2011.576681","article-title":"Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat","volume":"117","author":"Smith","year":"2011","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0130","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1152\/ajpregu.00072.2016","article-title":"Prior exercise training blunts short-term high-fat diet-induced weight gain","volume":"311","author":"Snook","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20919","article-title":"Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: discordant regulation of bile acid synthesis and gluconeogenesis","volume":"43","author":"Song","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0140","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.2337\/db13-0430","article-title":"Antipsychotic-induced insulin resistance and postprandial hormonal dysregulation independent of weight gain or psychiatric disease","volume":"62","author":"Teff","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0145","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1210\/jc.2008-1815","article-title":"Effects of olanzapine and haloperidol on the metabolic status of healthy men","volume":"95","author":"Vidarsdottir","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2017.05.005_bib0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4939-2929-0_17","article-title":"Glucose and insulin tolerance tests in the mouse","volume":"1339","author":"Vinue","year":"2015","journal-title":"Methods Mol. Biol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017301713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017301713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:56:26Z","timestamp":1759683386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453017301713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"alternative-id":["S0306453017301713"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.05.005","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2017.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}